A study for a 64 year old man who takes Pravastatin Sodium, Fenofibrate, Lisinopril - from FDA reports

Summary

2,524 males aged 64 (±5) who take the same drugs are studied. This is a personalized study for a 64 year old male patient who has Bp. The study is created by eHealthMe based on reports from FDA.



How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

What are the drugs?

What are the conditions?

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

2,524 males aged 64 (±5) who take Pravastatin Sodium, Fenofibrate, Lisinopril are studied.


Number of reports submitted per year:

Pravastatin Sodium, Fenofibrate, Lisinopril for a 64-year old man.

Information of the patient in this study:

  • Age: 64
  • Gender: male
  • Conditions: Bp
  • Drugs taken:
    • Pravastatin Sodium (pravastatin sodium)
    • Fenofibrate (fenofibrate)
    • Lisinopril (lisinopril)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Weakness
  2. Gait disturbance
  3. Renal failure acute (rapid kidney dysfunction)
  4. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  5. Weight decreased
  6. Anaemia (lack of blood)
  7. Skin discoloration
  8. Joint pain
  9. Blood urea increased
  10. Rash macular (small, flat red spots)
1 - 6 months:
  1. Nausea and vomiting
  2. Abdominal pain
  3. Fluid overload (too much fluid in the blood)
  4. Back pain
  5. Osteoporosis (bones weak and more likely to break)
  6. Hepatotoxicity (chemical-driven liver damage)
  7. Diabetic foot
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Angioedema (rapid swelling of the dermis)
  10. Dialysis
6 - 12 months:
  1. Breathing difficulty
  2. Heart rate irregular
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Bronchial infection
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Swallowing difficulty
  7. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Weight decreased
  10. Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles)
1 - 2 years:
  1. Interstitial nephritis (inflammation of the kidney)
  2. Glomerular filtration rate abnormal
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  6. Bronchial infection
  7. Hyperpyrexia (extremely high fever)
  8. Respiratory acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease)
  9. Chronic kidney disease
  10. Liver function test abnormal
2 - 5 years:
  1. Acute kidney failure
  2. Gastric ulcer (stomach ulcer)
  3. Pain
  4. Chronic kidney disease
  5. Dehydration (dryness resulting from the removal of water)
  6. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  7. Renal failure acute (rapid kidney dysfunction)
  8. Stress and anxiety
  9. Injury
  10. Emotional distress
5 - 10 years:
  1. Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest))
  2. Renal injury (kidney injury)
  3. Procedural haemorrhage (procedural bleeding)
  4. Chronic kidney disease
  5. Aortic dissection
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. Death
  8. Pre-existing condition improved
  9. Dehydration (dryness resulting from the removal of water)
  10. Lactic acidosis (low ph in body tissues)
10+ years:
  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Thrombosis (formation of a blood clot inside a blood vessel)
  3. Face injury
  4. Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
  5. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  6. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
  7. Post procedural haemorrhage (post procedural bleeding)
  8. Heart disease
  9. Pericardial effusion (fluid around the heart)
  10. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen)
not specified:
  1. Fatigue (feeling of tiredness)
  2. Drug ineffective
  3. Nausea (feeling of having an urge to vomit)
  4. Weakness
  5. Breathing difficulty
  6. Diarrhea
  7. Heart attack
  8. Blood glucose increased
  9. Weight decreased
  10. Dizziness

Top conditions involved for these people *:

  1. Diabetes : 319 people, 12.64%
  2. Type 2 Diabetes : 223 people, 8.84%
  3. Pain : 173 people, 6.85%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 155 people, 6.14%
  5. Depression : 148 people, 5.86%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 143 people, 5.67%
  7. Cardiac Disorder : 128 people, 5.07%
  8. Hyperlipidaemia (presence of excess lipids in the blood): 120 people, 4.75%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 99 people, 3.92%
  10. Multiple Myeloma (cancer of the plasma cells): 98 people, 3.88%

Top co-used drugs for these people *:

  1. Metformin (416 people, 16.48%)
  2. Aspirin (386 people, 15.29%)
  3. Plavix (297 people, 11.77%)
  4. Lasix (220 people, 8.72%)
  5. Lantus (212 people, 8.40%)
  6. Amlodipine (209 people, 8.28%)
  7. Coreg (159 people, 6.30%)
  8. Fish Oil (153 people, 6.06%)
  9. Lipitor (151 people, 5.98%)
  10. Norvasc (147 people, 5.82%)

* Some reports may have incomplete information.

What is next?

You are not alone:


Related publications that referenced our studies



Related studies:



FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.